NO20032489L - Guanidin- og amidinderivater som faktor Xa-inhibitorer - Google Patents

Guanidin- og amidinderivater som faktor Xa-inhibitorer

Info

Publication number
NO20032489L
NO20032489L NO20032489A NO20032489A NO20032489L NO 20032489 L NO20032489 L NO 20032489L NO 20032489 A NO20032489 A NO 20032489A NO 20032489 A NO20032489 A NO 20032489A NO 20032489 L NO20032489 L NO 20032489L
Authority
NO
Norway
Prior art keywords
guanidine
inhibitors
factor
amidine derivatives
amidine
Prior art date
Application number
NO20032489A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032489D0 (no
Inventor
Anuschirwan Peyman
David William Will
Uwe Gerlach
Marc Nazare
Gerhard Zoller
Hans-Peter Nestler
Hans Matter
Fahad Al-Obeidi
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20032489D0 publication Critical patent/NO20032489D0/no
Publication of NO20032489L publication Critical patent/NO20032489L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20032489A 2000-12-06 2003-06-02 Guanidin- og amidinderivater som faktor Xa-inhibitorer NO20032489L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00126750 2000-12-06
PCT/EP2001/013874 WO2002046159A1 (en) 2000-12-06 2001-11-28 Guanidine and amidine derivatives as factor xa inhibitors

Publications (2)

Publication Number Publication Date
NO20032489D0 NO20032489D0 (no) 2003-06-02
NO20032489L true NO20032489L (no) 2003-07-25

Family

ID=8170585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032489A NO20032489L (no) 2000-12-06 2003-06-02 Guanidin- og amidinderivater som faktor Xa-inhibitorer

Country Status (26)

Country Link
US (2) US20020173656A1 (xx)
EP (1) EP1345900B1 (xx)
JP (1) JP4274522B2 (xx)
KR (1) KR20040015036A (xx)
CN (1) CN1479722A (xx)
AR (1) AR033684A1 (xx)
AU (2) AU3320602A (xx)
BR (1) BR0115938A (xx)
CA (1) CA2430518C (xx)
CZ (1) CZ20031554A3 (xx)
DE (1) DE60126143T2 (xx)
DK (1) DK1345900T3 (xx)
EE (1) EE200300192A (xx)
ES (1) ES2278798T3 (xx)
HR (1) HRP20030447A2 (xx)
HU (1) HUP0302604A3 (xx)
IL (2) IL156214A0 (xx)
MX (1) MXPA03004848A (xx)
NO (1) NO20032489L (xx)
NZ (1) NZ526269A (xx)
PL (1) PL362320A1 (xx)
PT (1) PT1345900E (xx)
RU (1) RU2003120070A (xx)
SK (1) SK6862003A3 (xx)
WO (1) WO2002046159A1 (xx)
ZA (1) ZA200303847B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1703395A (zh) * 2002-08-09 2005-11-30 特兰斯泰克制药公司 芳基和杂芳基化合物以及调节凝血的方法
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
US7501538B2 (en) 2003-08-08 2009-03-10 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
WO2005014533A2 (en) * 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions, and methods of use
US8603481B2 (en) * 2003-10-10 2013-12-10 Chugai Seiyaku Kabushiki Kaisha Therapeutic agents for solid tumors
ATE483708T1 (de) 2004-03-08 2010-10-15 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
ATE424821T1 (de) 2004-12-02 2009-03-15 Prosidion Ltd Pyrrolopyridin-2-karbonsäureamide
DE102006048300A1 (de) * 2006-01-26 2007-08-02 Hellstern, Peter, Prof. Dr.med. Inhibitoren des Blutgerinnungsfaktors Xa zur Verwendung als Antikoagulans
WO2010098866A1 (en) 2009-02-27 2010-09-02 Supergen, Inc. Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors
US8507640B2 (en) 2010-08-19 2013-08-13 International Business Machines Corporation Methods of ring opening polymerization and catalysts therefor
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
MA49566A (fr) 2017-07-11 2020-05-20 Vertex Pharma Carboxamides utilisés en tant qu'inhibiteurs des canaux sodiques
IL272838B2 (en) 2017-10-06 2023-09-01 Forma Therapeutics Inc Peptidase-specific ubiquitin inhibition 30
SG11202011299PA (en) 2018-05-17 2020-12-30 Forma Therapeutics Inc Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors
PE20211053A1 (es) 2018-10-05 2021-06-07 Forma Therapeutics Inc Inhibicion de la proteasa 30 especifica de la ubiquitina (usp30)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201303B (xx) * 1990-07-05 1993-03-01 Hoffmann La Roche
US5506134A (en) 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5833982A (en) 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
ES2103181B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Amidas naftalenicas con accion antagonista de los leucotrienos.
SK286094B6 (sk) * 1994-04-26 2008-03-05 Aventis Pharmaceuticals Inc. Zlúčenina špecificky inhibujúca aktivitu faktora Xa, farmaceutická kompozícia s jej obsahom a jej použitie
US5792769A (en) * 1995-09-29 1998-08-11 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
TW542822B (en) * 1997-01-17 2003-07-21 Ajinomoto Kk Benzamidine derivatives
US6417200B1 (en) * 1997-06-26 2002-07-09 Eli Lilly And Company Antithrombotic agents
BR9909086A (pt) * 1998-03-23 2001-09-04 Aventis Pharm Prod Inc Derivados de piperidinila e n-amidinopiperidinila
US20020016339A1 (en) * 1998-03-23 2002-02-07 Klein Scott I. Piperididinyl and N-amidinopiperidinyl derivatives
EP0987274A1 (en) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
KR20020047175A (ko) * 1999-09-17 2002-06-21 밀레니엄 파머슈티컬스 인코퍼레이티드 Xa 인자의 억제제

Also Published As

Publication number Publication date
EP1345900A1 (en) 2003-09-24
IL156214A0 (en) 2003-12-23
KR20040015036A (ko) 2004-02-18
HUP0302604A3 (en) 2005-09-28
NO20032489D0 (no) 2003-06-02
AU2002233206B2 (en) 2006-06-22
HRP20030447A2 (en) 2005-04-30
CA2430518A1 (en) 2002-06-13
EP1345900B1 (en) 2007-01-17
ZA200303847B (en) 2004-04-15
RU2003120070A (ru) 2004-12-27
CA2430518C (en) 2010-06-15
DK1345900T3 (da) 2007-05-21
WO2002046159A1 (en) 2002-06-13
SK6862003A3 (en) 2004-02-03
AU3320602A (en) 2002-06-18
PT1345900E (pt) 2007-03-30
EE200300192A (et) 2003-08-15
CZ20031554A3 (cs) 2003-08-13
HUP0302604A2 (hu) 2003-11-28
JP2004515492A (ja) 2004-05-27
NZ526269A (en) 2004-11-26
BR0115938A (pt) 2003-12-23
US20020173656A1 (en) 2002-11-21
DE60126143D1 (de) 2007-03-08
MXPA03004848A (es) 2003-08-19
PL362320A1 (en) 2004-10-18
IL156214A (en) 2010-05-31
AR033684A1 (es) 2004-01-07
DE60126143T2 (de) 2007-11-15
CN1479722A (zh) 2004-03-03
JP4274522B2 (ja) 2009-06-10
US7435747B2 (en) 2008-10-14
US20050143419A1 (en) 2005-06-30
ES2278798T3 (es) 2007-08-16

Similar Documents

Publication Publication Date Title
NO20001687D0 (no) Benzamidinderivater som faktor Xa-inhibitorer
NO20021230L (no) Faktor Xa inhibitorer
NO20041163L (no) Laktam-inneholdende forbindelser og derivater derav som faktor XA-inhibitorer
NO20042592L (no) Indol-2-karboksamider som faktor XA inhibitorer
DK0991638T3 (da) Hidtil ukendte guanidinmimetika som faktor Xa-inhibitorer
DK1526132T3 (da) Substituerede oxazolidinoner og deres anvendelse som faktor Xa-hæmmer
NO20013072L (no) Nitrogenholdige heterocykler som faktor Xa-inhibitorer
NO20034439D0 (no) Benzamidinderivater
NO20026010L (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
DK1345900T3 (da) Guanidin- og amidinderivater som faktor XA-inhibitorer
ATE372988T1 (de) Pyrimidin-derivate
DE60103278D1 (de) Beschichtete gegenstände
NO20002958D0 (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
NO20033350L (no) Imidazolyl-derivater som kortikotropin-frigjörende faktor inhibitorer
NO20025810L (no) Faktor VIIA-inhibitoriske (tio)ureaderivater, deres fremstilling og anvendelse
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
DK1395553T3 (da) Pyrrolidinderivater som faktor Xa-inhibitorer
ATE246707T1 (de) Faktor viia inhibitore
NO20014234D0 (no) Pyrazol-3-on-derivater som faktor-Xa-inhibitorer
NO20032754L (no) Urea- og/eller uretanderivater som integrininhibitorer
NO20030796D0 (no) Aza-aminosyrederivater (faktor Xa-inhibitorer 15)
DE60206376D1 (de) Faktor xa inhibitor
DK1200409T3 (da) Substituerede isoquinolinderivater og deres anvendelse som krampestillende midler
NO20020592D0 (no) Fluorenderivater som integrininhibitorer
IS6418A (is) Sakkarínafleiður sem elastasatálmar, virkir í munni

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application